Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Modulation of immune system activity
- Molecular classification
- Other (process, not a molecule; interventions can target receptors, cytokines, enzymes, etc.)
01
Overview
"Modulation of immune system activity" refers broadly to pharmacological, biological, or genetic interventions designed to alter the behavior and function of the immune system. Such modulation can involve amplifying or suppressing specific aspects of the innate or adaptive immune response, with therapeutic applications in cancer, autoimmunity, infection, inflammation, aging, and regenerative medicine. Drugs and biologics can target diverse molecular pathways, including cytokines, immune cell receptors, signaling molecules, and transcriptional machinery, and frequently require careful patient selection and monitoring due to the risk of over- or under-activation of immune functions and related side effects.
- Other names
- immune modulationimmunomodulationimmune system modulationimmunoregulatory intervention
02
Mechanism of action
Cytokine signaling modulation; T-cell inhibition or activation; Checkpoint blockade (CTLA-4, PD-1/PD-L1); Pattern recognition receptor agonism (TLRs); Restoration/enhancement of immune cell proliferation
03
Biological functions
Immune responseInflammation regulationImmune cell activation/inhibitionRestoration of homeostasisRegulation of adaptive and innate immunities
04
Disease associations
CancerAutoimmune diseasesInflammationInfectionAge-related dysfunction ("immunosenescence")Other (chronic diseases, transplant rejection, etc.)
05
Safety considerations
Off-target immune activation (cytokine release syndrome)Autoimmune reactionsIncreased risk of infectionImmunosuppressionOrgan-specific toxicities
06
Interacting drugs
Interferons (e.g., IFN-β, IFN-α)
5 more in the full profile.
07
Biomarkers
PD-L1 expressionTumor-infiltrating lymphocytesCytokine levels (e.g., IFN-γ, IL-6)Immune cell subset counts (e.g., CD4+, CD8+ T cells)Signs of immunosenescence
Beyond the preview
Go deeper on Modulation of immune system activity.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Modulation of immune system activity.